Key Highlights

  • Third quarter sales rose 10.5% to USD 891.2 million, topping the USD 857.5 million estimate.
  • Adjusted EPS of USD 0.86 beat the USD 0.80 estimate, while GAAP EPS reached USD 0.46.
  • Adjusted EBITDA Margin hit a third quarter record 17.3%, up 80 basis points from a year earlier.
  • Full year adjusted EPS guidance moved to USD 3.22 to USD 3.32, with USD 50 million of Debt repaid.

Avient (NYSE:AVNT) reported third quarter sales of USD 891.2 million, up from USD 806.5 million a year earlier and ahead of the USD 857.5 million estimate. Adjusted EPS of USD 0.86 exceeded the USD 0.80 estimate and rose 23% year over year. On a GAAP basis, Net Income attributable to shareholders was USD 42.7 million, compared with USD 32.6 million, or USD 0.46 per diluted share against USD 0.36.

Segment Strength and Regional Mix

Organic sales grew 10.6%, with Volume up about 1% and pricing and mix supplying the rest. Management tied the mix benefit to functional additives such as chemical foaming agents and barrier technologies. The Color Additives and Ink segment posted 8% organic growth and 15% higher EBITDA, with its margin widening 120 basis points to 20.1%. The Specialty Engineered Materials segment grew Organic Sales 15%, with eight of nine end markets contributing, and its margin expanded 140 basis points to 21.3%.

Every region delivered organic growth. Asia rose 20% after an 18% gain in the second quarter, helped by Demand for high performance computing and electronics. Growth in EMEA was more muted, held back by weaker consumer, industrial and transportation demand. Healthcare sales in Specialty Engineered Materials returned to double digit growth after customers worked down inventories of drug delivery devices in the first half.

Margins, Cash and Capital Allocation

Adjusted EBITDA grew 16%, and the margin of 17.3% compares with 16.5% a year ago. Operating Income was USD 82.6 million, up from USD 67.1 million, while net interest expense eased to USD 22.7 million from USD 24.2 million. Nine month Operating Cash Flow reached USD 180.0 million, against USD 133.8 million in the same period of 2025, and cash stood at USD 445.7 million.

The company repaid USD 50 million of debt in the quarter, bringing reductions to USD 250 million over 18 months. In the fourth quarter to date it bought back 281 thousand shares for about USD 10.9 million, the first buyback since 2022. The quarterly Dividend was 27.5 cents per share, up from 27 cents. New chief executive Michael Frank, who joined about three weeks before the report, named profitable sales growth, adjusted EBITDA margin and free cash flow as his priority metrics.

Raised 2026 Guidance

Avient raised its full year ranges to adjusted EBITDA of USD 593 million to USD 603 million, adjusted EPS of USD 3.22 to USD 3.32 and adjusted free cash flow of USD 215 million to USD 230 million. Capital spending is projected near USD 120 million, versus USD 107 million in 2025. Management projects net Leverage of 2.2 to 2.3 times at year end, down from 2.6 times at the end of 2025. The outlook carries a caveat for macroeconomic uncertainty, including persistent Inflation and higher interest rates.

Metrics to Track

Third quarter adjusted EPS of USD 0.86 compares with a full year guide of USD 3.22 to USD 3.32, while the 17.3% adjusted EBITDA margin sits against 16.5% a year ago. Organic sales growth of 10.6% compares with roughly 1% volume growth, and net leverage of 2.2 to 2.3 times projected for year end compares with 2.6 times at the end of 2025.